Mapping the Inflammation Research Landscape in Myocardial Infarction, 1995-2025: A Bibliometric Analysis of WoSCC and PubMed Authors: Yang Liu, Sicheng Chen, Ting Li, Yang Hu, Zongrong Lin, Yiming Fu, Zhenyang Fu Published: 2026 ABSTRACT PurposeInflammation contributes to coronary plaque instability, myocardial injury, tissue repair, ventricular remodeling, recurrent cardiovascular events, and heart failure after myocardial infarction. This study aimed to map the publication patterns, conceptual structure, and thematic evolution of myocardial infarction-related inflammation research from 1995 to 2025.MethodsEnglish-language articles and reviews published from 1995 to 2025 were retrieved from the Web of Science Core Collection (WoSCC) and PubMed on July 29, 2026, using database-specific but conceptually harmonized strategies. All retrieved records underwent title and abstract screening against prespecified eligibility criteria, and proposed exclusions were independently verified by two authors. WoSCC was used for the primary bibliometric and science-mapping analyses and PubMed for complementary Medical Subject Headings (MeSH)-based analyses. The datasets were processed separately and were not merged or deduplicated across databases. Bibliometrix, VOSviewer, CiteSpace, and Microsoft Excel were used to examine publication growth, geographic and institutional contributions, collaboration networks, conceptual structure, thematic evolution, citation bursts, and interdisciplinary knowledge flow.ResultsAfter screening, 5,446 WoSCC records and 4,494 PubMed records were included. Publication output increased substantially in both databases, although the timing of short-term fluctuations differed. China and the United States were the leading national contributors, while major academic medical centers occupied central positions in collaboration networks. Multiple correspondence analysis of the WoSCC dataset yielded four algorithmic clusters that supported an interpretive framework of three broader domains: clinical inflammatory risk and prognosis, coronary vascular inflammation, and post-infarction inflammatory injury and repair. PubMed MeSH analyses provided complementary clinical and mechanistic patterns. Temporal analyses showed a shift from thrombolysis, conventional inflammatory markers, adhesion molecules, and vascular complications toward ischemia-reperfusion injury, inflammasome signaling, systemic immune-inflammatory indices, immune-cell regulation, biomarkers, and post-infarction remodeling.ConclusionMyocardial infarction-related inflammation research has expanded from conventional biomarker and vascular studies toward a broader literature encompassing coronary inflammation, inflammatory injury and repair, ventricular remodeling, and risk stratification. The separate WoSCC and PubMed analyses provide complementary maps of research prominence and thematic relationships. The proposed domain framework and translational gaps should be interpreted as hypotheses generated from bibliometric patterns rather than evidence of biological causality, clinical validity, or therapeutic efficacy. Introduction Myocardial infarction remains a major contributor to cardiovascular morbidity and mortality worldwide.1 Clinically, myocardial infarction is defined by evidence of acute myocardial injury in the setting of myocardial ischemia.2 Beyond cardiomyocyte death, ischemic injury activates inflammatory signaling, recruits circulating immune cells, and initiates a repair response that influences scar formation, ventricular remodeling, and the subsequent risk of heart failure.3,4 Inflammation after myocardial infarction is not simply harmful. An early inflammatory phase is required to remove necrotic debris and initiate tissue repair.5 The same response, when excessive, prolonged, or poorly resolved, can contribute to microvascular dysfunction, extracellular matrix remodeling, ventricular dilation, and adverse outcomes.3,4 This dual role has made post-infarction inflammation an important but complex area of cardiovascular research.6 Immune cells, vascular cells, fibroblasts, and cardiomyocytes participate in the inflammatory and reparative phases after myocardial infarction.3,4,7,8 Cytokines, chemokines, damage-associated molecular patterns, oxidative stress, complement activation, and inflammasome signaling further connect local myocardial injury with systemic inflammatory responses.3,4,9 These inflammatory cells and mediators have also prompted clinical studies of circulating biomarkers, residual inflammatory risk, and inflammation-targeted interventions.9–12 The focus of the field has changed substantially over time. Earlier work often emphasized thrombolysis, C-reactive protein, adhesion molecules, atherosclerosis, and prognosis.13,14 More recent studies have increasingly examined ischemia-reperfusion injury, NLRP3 inflammasome activation, immune-cell heterogeneity, mitochondrial stress, systemic immune-inflammatory indices, and remodeling-related mechanisms.7,9,15–17 Consequently, myocardial infarction-related inflammation research now spans coronary vascular inflammation, innate and adaptive immune responses, inflammatory mediators, myocardial injury and repair, pharmacology, and biomarker-based risk assessment. Several bibliometric studies have addressed narrower components of this literature, including anti-inflammatory research in coronary heart disease, macrophage-centered research after myocardial infarction, and NLRP3 inflammasome-related research in cardiovascular disease.15–17 These studies characterize important disease-, cell-, or pathway-specific perspectives, but they do not provide a myocardial infarction-centered map spanning clinical inflammatory risk, coronary vascular inflammation, post-infarction injury and repair, and therapeutic translation. WoSCC and PubMed also offer different forms of bibliographic evidence: WoSCC supports citation, collaboration, and science-mapping analyses, whereas PubMed MeSH terms provide standardized biomedical indexing. The need for a broader map is reinforced by the uneven translation of inflammation research into routine care. Circulating biomarkers such as C-reactive protein and blood-cell-based inflammatory indices are clinically accessible, but they do not by themselves identify the responsible cell populations, signaling pathways, treatment windows, or patient phenotypes. Conversely, mechanistic studies of inflammasomes, immune-cell states, oxidative stress, and ischemia-reperfusion injury have generated numerous candidate targets, but relatively few have become established clinical tools or guideline-supported therapies. Mapping how these research streams relate may therefore clarify both the structure of the field and its translational gaps. In this study, we mapped myocardial infarction-related inflammation research from 1995 to 2025 using WoSCC as the primary science-mapping dataset and PubMed as a complementary MeSH-based dataset. We examined publication growth, geographic and institutional contributions, collaboration patterns, journal distribution, conceptual structure, thematic evolution, citation bursts, and interdisciplinary knowledge flow. The databases were analyzed separately rather than treated as directly interchangeable datasets. We aimed to determine whether their distinct indexing systems revealed complementary views of clinical inflammatory risk, coronary vascular inflammation, and post-infarction injury and repair. Materials and Methods This study was designed as a bibliometric and science-mapping analysis of published literature on myocardial infarction and inflammation. WoSCC and PubMed were analyzed separately because their database coverage, indexing fields, author and affiliation structures, and citation metadata are not directly equivalent. WoSCC served as the primary dataset for bibliometric and science-mapping analyses, whereas PubMed provided a complementary MeSH-based perspective. Data Sources and Search Strategy WoSCC records were retrieved from the Science Citation Index Expanded using field-specific searches of titles (TI), author keywords (AK), and selected abstract terms (AB). PubMed records were retrieved using MeSH Major Topic fields and title terms. Both databases were searched and exported on July 29, 2026. The publication period was restricted to 1995–2025, and only English-language articles and reviews were eligible. The year 1995 was selected a priori to provide a complete 31-year observation window ending in 2025 and to capture the modern era of reperfusion, biomarker, and immune-inflammatory research after myocardial infarction. The two search strategies were conceptually harmonized while accounting for database-specific indexing. Myocardial infarction terms were required in the title or author keywords in WoSCC, or as a MeSH Major Topic or title term in PubMed. Broad inflammatory and immune-cell terms were restricted mainly to titles or author keywords, with only a limited set of highly specific inflammation-related terms permitted in WoSCC abstracts. The complete Boolean operators, field tags, wildcards, date limits, language restrictions, and publication-type filters are provided in Supplementary Tables S1 and S2. Eligibility Criteria and Record Screening Eligible records were English-language Articles or Reviews with a final publication year from January 1, 1995 to December 31, 2025 and a direct, substantive relationship between myocardial infarction (MI) and inflammation or immune-inflammatory processes. The eligible scope included inflammatory responses, biomarkers, prognosis, risk stratification, complications, and outcomes in MI; coronary or atherosclerotic inflammation directly related to MI occurrence, plaque instability, rupture, thrombosis, or infarction risk; post-MI immune inflammation, injury, repair, fibrosis, remodeling, and heart failure; MI-related myocardial ischemia-reperfusion injury; MI-related immune-cell, cytokine, chemokine, inflammasome, and NLRP3 research; and anti-inflammatory or immunomodulatory interventions related to MI occurrence, injury, repair, prognosis, or secondary prevention. Human, animal, cellular, and translational studies were eligible. Records addressing coronary or systemic inflammatory processes were retained when a direct mechanistic, clinical, or prognostic link to MI was evident, even when MI was evaluated as a subsequent outcome rather than the initial study population. Records were excluded when MI appeared only as background information or one component of a broad composite outcome in studies primarily focused on unrelated diseases; when inflammatory or immune-related terms were incidental to the principal research question; or when the study focused on another cardiovascular or systemic disease without a direct relationship to MI occurrence, post-MI complications, or post-MI remodeling. Case reports, editorials, letters, comments, protocols, corrections or errata, preprints, book chapters, retracted publications, and retraction notices were excluded, as were records with a final publication year outside 1995–2025 and within-database duplicates. All retrieved records were screened at the title and abstract level against these prespecified criteria. Two authors independently verified all proposed exclusions, and disagreements were resolved by consensus. In WoSCC, 263 thematically irrelevant records and 47 unique records with ineligible publication status or type were removed; the latter category included overlapping labels for retracted publications, protocols, and case reports. In PubMed, 65 thematically irrelevant records and 9 records with ineligible publication status or type were removed. No cross-database merging or deduplication was performed. The detailed eligibility rules are provided in Supplementary Table S3. Data Extraction and Term Standardization For each database, bibliographic fields were extracted for publication year, title, source, authors, institutional affiliations, corresponding-author country, document type, identifiers, and keyword-related information. DOI and citation information were obtained from WoSCC where available, and PMID information was obtained from PubMed. WoSCC Author Keywords were used for the principal thematic and temporal analyses; Keywords Plus were incorporated only in analyses explicitly specified in the figure legends and parameter table PubMed analyses used MeSH terms. Before analysis, terms were standardized for capitalization, punctuation, hyphenation, British/American spelling, singular/plural forms, and clear abbreviation or synonym variants. Biologically or clinically distinct concepts were not merged solely because they were related. The extracted fields and full normalization thesaurus are provided in Supplementary Tables S4 and S6. Bibliometric and Visualization Analyses Bibliometric analyses were performed using R version 4.5.1 with the bibliometrix package version 4.3.2, VOSviewer version 1.6.20, CiteSpace version 6.4.R1 (64-bit Basic), and Microsoft Excel. Bibliometrix was used to summarize publication trends, source distribution, national and institutional productivity, author productivity, thematic maps, conceptual structure, thematic evolution, and Trend Topics. VOSviewer was used for collaboration, keyword co-occurrence, and journal co-citation networks. CiteSpace was used for keyword clustering, citation-burst detection, and the journal dual-map overlay. Thematic maps were generated using Louvain clustering, and conceptual structure was examined by multiple correspondence analysis. The thematic evolution analysis used three prespecified periods: 1995–2004, 2005–2014, and 2015–2025. Standard software settings were retained unless otherwise stated. VOSviewer networks used full counting and association-strength normalization; the standard clustering resolution was 1.0 with a minimum cluster size of 1. CiteSpace keyword clustering used the 1996–2025 time span, 1-year slices, and the Top 30 items per slice, with LRF=2.5, L/N=10, LBY=5, e=1.0, and no pruning. The resulting network contained 233 nodes and 1,383 links (density 0.0512), with a largest connected component of 193 nodes (82%). Cluster labels were generated automatically using the log-likelihood ratio method and interpreted with their underlying terms. The cluster solution had a modularity Q of 0.4864 and a weighted mean silhouette S of 0.8343. Detailed settings for each analysis are reported in Supplementary Table S5. PubMed analyses were used to determine whether broad temporal, geographic, and thematic patterns were also observable under standardized biomedical indexing. They were not treated as a direct replication or formal validation of WoSCC analyses because MeSH terms, WoSCC keywords, author names, and affiliation fields are generated and indexed differently. Cross-database similarities were therefore described qualitatively and not interpreted as formal agreement statistics. Annual publication counts were summarized descriptively. Second-order polynomial curves were displayed only to visualize the long-term shape of publication growth and were not used to explain year-specific fluctuations, identify causal breakpoints, forecast future output, or test the effects of individual clinical trials. Results Growth of Myocardial Infarction-Related Inflammation Research The WoSCC search identified 5,756 records. After removal of 263 thematically irrelevant records and 47 unique records with ineligible publication status or type, 5,446 records were retained for analysis (Figure 1A). These records were distributed across 979 sources and involved 25,030 authors. The annual growth rate was 10.91%, the mean number of co-authors per document was 8.08, and the international co-authorship rate was 20.58%. The mean citation count was 45.9 per document (Figure 1B). The PubMed search identified 4,568 records; after removal of 65 thematically irrelevant records and 9 records with ineligible publication status or type, 4,494 remained (Supplementary Figure S1A). The PubMed dataset covered 1,201 sources and 20,401 authors, with an annual growth rate of 9.45%, 7.92 co-authors per document, and an international co-authorship rate of 9.902%. Reference and citation indicators unavailable in PubMed were reported as not available rather than zero (Supplementary Figure S1B). Figure 1Bibliometric overview and temporal publication patterns of studies on myocardial infarction and inflammation retrieved from the Web of Science Core Collection (WoSCC), 1995–2025. (A) Flowchart of field-specific database retrieval, title/abstract eligibility screening, and final inclusion. A total of 310 records were removed: 263 thematically irrelevant records and 47 unique records with ineligible publication status or document type. The latter category included overlapping labels for retracted publications, protocols, and case reports. (B) Core bibliometric indicators of the 5,446 included WoSCC records. (C) Annual and cumulative publication counts. (D) Annual publication output with a descriptively fitted second-order polynomial curve; the curve was not used for causal inference, breakpoint detection, or forecasting.Image A outlines a bibliometric analysis flowchart. It begins with identifying 5756 publications from the Web of Science Core Collection (1995-2025). After removing retracted publications (25), protocols (10), case reports (14), irrelevant themes (263) and other ineligible documents (47), 5446 publications remain for analysis. Visualization tools include VOSviewer, R, CiteSpace and Excel. Categories analyzed are publications, countries, authors, affiliations, journals and keywords. Image B presents bibliometric indicators: 979 sources, 5446 documents, 10.91% annual growth, 25030 authors, 67 single-authored documents, 20.58% international co-authorship, 8.08 co-authors per document, 7249 keywords, 138112 references, document average age 9.54 years and 45.9 average citations per document. Image C displays a bar chart of publication numbers (1995-2025). Image D shows a line graph of annual publications with a polynomial curve: y = 0.645x superscript 2 + 0.848x + 29.486, R superscript 2 = 0.9111.Bibliometric analysis of publications (1995-2025): growth rates & citation metrics overview. Bibliometric overview and temporal publication patterns of studies on myocardial infarction and inflammation retrieved from the Web of Science Core Collection (WoSCC), 1995–2025. (A) Flowchart of field-specific database retrieval, title/abstract eligibility screening, and final inclusion. A total of 310 records were removed: 263 thematically irrelevant records and 47 unique records with ineligible publication status or document type. The latter category included overlapping labels for retracted publications, protocols, and case reports. (B) Core bibliometric indicators of the 5,446 included WoSCC records. (C) Annual and cumulative publication counts. (D) Annual publication output with a descriptively fitted second-order polynomial curve; the curve was not used for causal inference, breakpoint detection, or forecasting. Annual output increased markedly over the study period. WoSCC publications increased from 22 in 1995 to 492 in 2025 (Figure 1C and D). Output decreased from 437 in 2022 to 390 in 2023, followed by increases to 407 in 2024 and 492 in 2025. PubMed publications increased from 23 in 1995 to 345 in 2025; the PubMed series increased to 321 in 2023, declined to 299 in 2024, and increased again to 345 in 2025 (Supplementary Figure S1C and S1D). Because the short-term fluctuations occurred in different years, no shared cross-database event was inferred. The fitted curves were used only as descriptive visual summaries of long-term growth. Global and Institutional Contributions WoSCC-based country analysis showed that China had the largest publication output, followed by the United States, Germany, Japan, Iran, and other countries in Europe and Asia (Figure 2A). The balance between single-country and multiple-country publications differed across countries: China’s output was dominated by single-country publications, whereas the United States and several European countries showed comparatively larger internationally co-authored components. Figure 2Geographic distribution, institutional contributions, collaboration patterns, and source dynamics in research on myocardial infarction and inflammation based on WoSCC, 1995–2025. (A) Corresponding-author countries ranked by publication output; single-country publications (SCP) and multiple-country publications (MCP) are shown separately. (B) Ten most productive affiliations ranked by the number of included articles. (C) Global country collaboration map; darker shading indicates greater publication output and curved links indicate international co-authorship connections. (D) Cumulative source production over time for the leading journals. (E) Institutional collaboration network; node size reflects publication output, links represent co-authorship relationships, link thickness reflects collaboration strength, and colors indicate network clusters.A) Bar chart of corresponding author′s countries shows China leading in publication output, followed by the United States, Germany and others. SCP and MCP are distinguished. B) Dot plot of most relevant affiliations ranks Harvard University highest in article count. C) Global map illustrates country collaboration with darker shading for higher output and lines for co-authorship. D) Line graph of sources′ production over time shows cumulative document count from 1995 to 2025. E) Network diagram of institutional collaboration highlights node size for output and link thickness for collaboration strength, with clusters indicated.Infographic: research output, affiliations, collaborations, source dynamics in myocardial infarction studies. Geographic distribution, institutional contributions, collaboration patterns, and source dynamics in research on myocardial infarction and inflammation based on WoSCC, 1995–2025. (A) Corresponding-author countries ranked by publication output; single-country publications (SCP) and multiple-country publications (MCP) are shown separately. (B) Ten most productive affiliations ranked by the number of included articles. (C) Global country collaboration map; darker shading indicates greater publication output and curved links indicate international co-authorship connections. (D) Cumulative source production over time for the leading journals. (E) Institutional collaboration network; node size reflects publication output, links represent co-authorship relationships, link thickness reflects collaboration strength, and colors indicate network clusters. The global collaboration map showed extensive links among North America, Europe, and East Asia, with the United States, China, and several European countries acting as major collaboration nodes (Figure 2C). PubMed showed a complementary geographic pattern, again identifying China and the United States as high-output countries and demonstrating broad international links (Supplementary Figure S2A and S2C). Differences between the two maps were interpreted cautiously because corresponding-author country and affiliation fields are indexed differently in WoSCC and PubMed. Harvard University ranked first in WoSCC institutional output, followed by the University of Oslo and other major academic medical centers; Harvard University also occupied a central position in the institutional collaboration network (Figure 2B and E). In PubMed, Huazhong University of Science and Technology ranked first, followed by the Icahn School of Medicine at Mount Sinai, Fudan University, Renmin Hospital of Wuhan University, and the University of Oslo (Supplementary Figure S2B). Author production and collaboration analyses identified sustained contributions from several investigators and multiple collaboration communities in both databases (Supplementary Figure S3A–S3D). Source production increased over time in WoSCC (Figure 2D). Circulation ranked first by publication volume in both databases; other leading sources included Frontiers in Cardiovascular Medicine, International Journal of Cardiology, Atherosclerosis, Cardiovascular Research, Journal of Molecular and Cellular Cardiology, and related cardiovascular or biomedical journals (Supplementary Figure S4A and S4B). Clinical, Vascular, and Mechanistic Dimensions of Myocardial Infarction-Related Inflammation The WoSCC thematic map showed myocardial infarction, inflammation, heart failure, cytokines, and macrophage-related terms as central and comparatively developed themes (Figure 3A). NLRP3/inflammasome, pyroptosis, and colchicine formed a more specialized high-density group, whereas atherosclerosis, cardiovascular disease, stroke, thrombosis, risk factors, and epidemiology occupied lower-density positions. These locations describe relative centrality and internal cohesion within the keyword network and do not indicate biological importance. Figure 3Conceptual structure, thematic clustering, and keyword networks in research on myocardial infarction and inflammation based on WoSCC, 1995–2025. (A) Thematic map derived from author keywords. Centrality indicates relevance to the overall field, density indicates internal development, and bubble size reflects keyword frequency within each theme. (B) Multiple correspondence analysis map showing four algorithmic keyword clusters and their relative conceptual distances. (C) Keyword word cloud; word size is proportional to occurrence frequency. (D) CiteSpace keyword cluster map. Cluster labels were generated automatically from the citing literature. The overall solution had a modularity Q of 0.4864 and a weighted mean silhouette S of 0.8343. (E) VOSviewer keyword co-occurrence overlay. Node size is proportional to occurrence frequency, link thickness represents co-occurrence strength, and color indicates average publication year. Detailed inclusion thresholds and normalization settings are provided in the Supplementary Material.The infographic consists of five parts related to myocardial infarction and inflammation research. A shows a thematic map with four quadrants: NLRP3/inflammasome, pyroptosis and colchicine in the upper left; myocardial infarction, inflammation, heart failure, cytokines and macrophages in the upper right; atherosclerosis, cardiovascular disease, stroke, thrombosis, risk factors and epidemiology in the lower right; and reperfusion, oxidative stress and infarct size in the lower left. B presents a multiple correspondence analysis map with four keyword clusters: atherosclerosis, thrombosis and risk factors; inflammation and myocardial infarction; cytokines and macrophages; and oxidative stress and ischemia. C is a word cloud highlighting keywords like myocardial infarction, inflammation and atherosclerosis. D shows a CiteSpace keyword cluster map with clusters such as streptokinase, adenovirus-mediated gene transfer and modulating inflammation. E displays a VOSviewer keyword co-occurrence overlay with nodes and links representing keyword frequency and co-occurrence strength.Five-part infographic on myocardial infarction and inflammation research themes and keyword networks. Conceptual structure, thematic clustering, and keyword networks in research on myocardial infarction and inflammation based on WoSCC, 1995–2025. (A) Thematic map derived from author keywords. Centrality indicates relevance to the overall field, density indicates internal development, and bubble size reflects keyword frequency within each theme. (B) Multiple correspondence analysis map showing four algorithmic keyword clusters and their relative conceptual distances. (C) Keyword word cloud; word size is proportional to occurrence frequency. (D) CiteSpace keyword cluster map. Cluster labels were generated automatically from the citing literature. The overall solution had a modularity Q of 0.4864 and a weighted mean silhouette S of 0.8343. (E) VOSviewer keyword co-occurrence overlay. Node size is proportional to occurrence frequency, link thickness represents co-occurrence strength, and color indicates average publication year. Detailed inclusion thresholds and normalization settings are provided in the Supplementary Material. Multiple correspondence analysis yielded four algorithmic clusters (Figure 3B). Two clinically oriented clusters contained acute myocardial infarction, ST-segment elevation myocardial infarction, percutaneous coronary intervention, C-reactive protein, biomarkers, interleukins, epidemiology, and risk factors. A vascular cluster contained atherosclerosis, coronary artery disease, thrombosis, and cardiovascular disease. A larger mechanistic cluster contained myocardial ischemia-reperfusion injury, macrophages, monocytes, neutrophils, cytokines, inflammasome-related terms, apoptosis, oxidative stress, fibrosis, angiogenesis, and cardiac remodeling. For interpretation, the two clinical clusters were considered together, supporting three broader domains: clinical inflammatory risk and prognosis, coronary vascular inflammation, and post-infarction inflammatory injury and repair. This three-domain framework is an interpretive synthesis of the algorithmic clusters rather than a claim of biologically discrete compartments. Representative terms supporting the three interpretive domains are summarized in Supplementary Table S7. PubMed MeSH analyses provided a complementary conceptual view. The thematic map identified myocardial infarction, inflammation, cardiac/inflammatory concepts, C-reactive protein, and acute coronary descriptors as central themes (Supplementary Figure S6A). PubMed multiple correspondence analysis separated a large clinical and epidemiologic grouping from experimental animal, cellular, cytokine, apoptosis, remodeling, and signaling groupings, while retaining smaller clusters centered on myocardial infarction, inflammation, and biomarkers (Supplementary Figure S6B). The WoSCC word cloud was dominated by myocardial infarction and inflammation, followed by atherosclerosis, C-reactive protein, cardiovascular disease, acute myocardial infarction, risk, mortality, heart failure, oxidative stress, expression, and activation (Figure 3C). The PubMed MeSH density map similarly concentrated around myocardial infarction, inflammation, acute myocardial infarction, macrophage-related terms, cardiovascular disease, and risk or prognostic concepts (Supplementary Figure S2D). CiteSpace identified eight keyword clusters labeled C-reactive protein, myocardial infarction, cytokine expression, adenovirus-mediated gene transfer, canine model, modulating inflammation, factor, and streptokinase (Figure 3D). These labels were generated automatically from the citing literature and were interpreted together with the underlying terms rather than as stand-alone thematic conclusions. The cluster solution showed a modularity Q of 0.4864 and a weighted mean silhouette S of 0.8343. The VOSviewer overlay network was centered on myocardial infarction and inflammation, with a dense set of links to atherosclerosis, C-reactive protein, heart failure, immune cells, oxidative stress, reperfusion injury, and regulated cell-death terms; the color gradient indicated the average publication year of each term (Figure 3E). Evolution from Conventional Inflammatory Markers to Mechanistic and Immune-Inflammatory Themes WoSCC Trend Topics analysis showed a gradual change in research emphasis (Figure 4A). Earlier terms included streptokinase, endothelial and adhesion molecules, infection, free radicals, myocarditis, coronary disease, fibrinogen, unstable angina, nitric oxide, infarction, and reperfusion. Subsequent topics included interleukins, tumor necrosis factor-alpha, angioplasty, platelet activation, collagen, thrombolysis, remodeling, leukocytes, myeloperoxidase, magnetic resonance imaging, extracellular matrix, C-reactive protein, and monocyte-related terms. Recent topics included myocardial infarction, cardiac remodeling, macrophages, oxidative stress, macrophage polarization, pyroptosis, ferroptosis, systemic immune-inflammation index, major adverse cardiovascular events, anti-inflammatory therapy, machine learning, and older-patient populations. Figure 4Temporal evolution of research themes in studies on myocardial infarction and inflammation based on WoSCC, 1995–2025. (A) Trend Topics timeline. Bubble size reflects term frequency, and horizontal lines indicate the period over which each term was prominent. (B) Fifteen keywords with the strongest citation bursts in 1995–2004, 2005–2014, and 2015–2025. Red segments indicate burst periods.Image A displays a bubble timeline chart titled ′Trend Topics′ with the x-axis labeled ′Year′ (1995-2024) and the y-axis labeled ′Term,′ listing keywords like streptokinase, endothelium and machine learning. Each term has a horizontal line indicating its active years, with bubble sizes representing term frequency (1000 or 2000). Early terms include streptokinase (1995-2002), while recent terms like machine learning appear around 2022-2024. Image B features three tables titled ′Top 15 Keywords with the Strongest Citation Bursts,′ covering periods 1995-2004, 2005-2014 and 2015-2025. Each table lists 15 keywords with columns for ′Keywords,′ ′Year Strength,′ ′Begin,′ ′End,′ and a timeline from 1995 to 2025, showing the burst interval for each keyword.Two bibliometric timelines of myocardial infarction and inflammation keywords and citation bursts over years. Temporal evolution of research themes in studies on myocardial infarction and inflammation based on WoSCC, 1995–2025. (A) Trend Topics timeline. Bubble size reflects term frequency, and horizontal lines indicate the period over which each term was prominent. (B) Fifteen keywords with the strongest citation bursts in 1995–2004, 2005–2014, and 2015–2025. Red segments indicate burst periods. The three-period thematic evolution analysis provided a direct temporal view of the major research streams (Supplementary Figure S5). During 1995–2004, C-reactive protein, inflammation, myocardial infarction, coronary heart disease, cytokines, and interleukins formed the principal streams. During 2005–2014, myocardial infarction remained dominant, while cytokines, acute myocardial infarction, and reperfusion gained prominence. During 2015–2025, myocardial infarction and acute myocardial infarction remained central, with atherosclerosis and other mechanistic or clinical terms continuing as connected streams. PubMed trend and cumulative-frequency analyses showed the continued growth of clinical, animal-model, macrophage, inflammation, fibrosis, and remodeling-related MeSH concepts (Supplementary Figure S7A and S7B). Keyword burst analysis was summarized in three periods (Figure 4B). The earliest bursts involved ischemia, reperfusion injury, tumor necrosis factor, adhesion molecules, acute myocardial infarction, angina, cytokines, coronary disease, smooth muscle cells, and prognostic terms. During 2005–2014, bursts included cardiac myocytes, gene expression, interleukin-6, tumor necrosis factor, smooth muscle cells, nitric oxide, susceptibility, serum levels, infarction, monocyte chemoattractant protein-1, ischemic heart disease, monocyte subsets, receptors, and dendritic cells. During 2015–2025, bursts shifted toward mice, reperfusion, heart failure, long-term mortality, neutrophil/lymphocyte ratio, C-reactive protein, cardiovascular disease, biomarkers, cardiac remodeling, reperfusion injury, size, neutrophils, cardiac function, and protective effects. Knowledge Flow Between Clinical Cardiovascular and Inflammation Research The journal co-citation network contained a large clinical cardiovascular cluster centered on Circulation, Journal of the American College of Cardiology, International Journal of Cardiology, Atherosclerosis, Arteriosclerosis, Thrombosis, and Vascular Biology, and related journals (Figure 5A). A second major cluster included cardiovascular biology, molecular and cellular cardiology, physiology, immunology, pharmacology, biomaterials, and translational journals. Dense cross-cluster links indicated frequent co-citation between clinical and mechanism-oriented literatures. Figure 5Journal co-citation structure and interdisciplinary knowledge-flow pathways in research on myocardial infarction and inflammation. (A) VOSviewer journal co-citation network. Node size reflects co-citation frequency, links indicate co-citation relationships, link thickness represents co-citation strength, and colors denote journal clusters. (B) CiteSpace journal dual-map overlay. The left side represents citing journal domains, the right side represents cited journal domains, and curved lines indicate major citation pathways between disciplines.The image A shows a VOSviewer journal co-citation network. Node size reflects co-citation frequency, links indicate co-citation relationships and link thickness represents co-citation strength. The network contains a large clinical cardiovascular cluster centered on journals like Circulation, Journal of the American College of Cardiology, International Journal of Cardiology, Atherosclerosis, Arteriosclerosis, Thrombosis and Vascular Biology. A second major cluster includes cardiovascular biology, molecular and cellular cardiology, physiology, immunology, pharmacology, biomaterials and translational journals. Dense cross-cluster links indicate frequent co-citation between clinical and mechanism-oriented literatures. The image B shows a CiteSpace journal dual-map overlay. The left side represents citing journal domains, the right side represents cited journal domains and curved lines indicate major citation pathways between disciplines.Two diagrams: A journal co-citation network and a journal dual-map overlay. Journal co-citation structure and interdisciplinary knowledge-flow pathways in research on myocardial infarction and inflammation. (A) VOSviewer journal co-citation network. Node size reflects co-citation frequency, links indicate co-citation relationships, link thickness represents co-citation strength, and colors denote journal clusters. (B) CiteSpace journal dual-map overlay. The left side represents citing journal domains, the right side represents cited journal domains, and curved lines indicate major citation pathways between disciplines. The dual-map overlay showed citation pathways from medicine and clinical medicine, as well as molecular biology and immunology, toward cited domains in molecular biology and genetics, health and medicine, and related biomedical sciences (Figure 5B). Representative conceptual exchanges include the movement of immune-cell, cytokine, inflammasome, and molecular-injury concepts into cardiovascular research, and the use of clinical myocardial infarction, reperfusion, biomarker, and outcome frameworks in broader medical research. These examples are field-level interpretations of citation pathways rather than paper-level directional tracing. Discussion This study mapped myocardial infarction-related inflammation research from 1995 to 2025 using WoSCC as the primary science-mapping dataset and PubMed as a complementary MeSH-based dataset. After relevance and publication-type screening, 5,446 WoSCC records and 4,494 PubMed records were analyzed separately. Both datasets showed substantial long-term growth and a shift from conventional inflammatory markers and vascular complications toward immune-cell regulation, ischemia-reperfusion injury, inflammasome signaling, systemic immune-inflammatory indices, regulated cell death, and post-infarction remodeling. The principal contribution of the study is a structured synthesis of a large and heterogeneous literature rather than the discovery of a new biological mechanism. WoSCC multiple correspondence analysis produced four algorithmic clusters, including two clinically oriented clusters, one vascular cluster, and one broad mechanistic cluster. Grouping the two clinical clusters together supported an interpretive three-domain framework comprising clinical inflammatory risk and prognosis, coronary vascular inflammation, and post-infarction inflammatory injury and repair. The framework is therefore a higher-level interpretation of the mapped relationships and should not be understood as proof that these domains are biologically separate. Several developments likely contributed to the expansion of the field. Improved reperfusion and secondary prevention increased survival after myocardial infarction and intensified interest in recurrent events, heart failure, and ventricular remodeling.18,19 Advances in transcriptomics, single-cell analysis, immune phenotyping, imaging, biomarker profiling, and experimental models also enabled more detailed study of inflammatory cell states and injury-repair mechanisms. In parallel, major anti-inflammatory trials, including CANTOS, COLCOT, and LoDoCo2, increased clinical attention to residual inflammatory risk and pathway-targeted therapy.10–12 The revised annual series does not show a simultaneous decline in the same year across the two databases. WoSCC output decreased in 2023 and then recovered, whereas PubMed showed a modest decline in 2024 before increasing in 2025. These short-term variations may reflect publication cycles, indexing processes, or other unmeasured factors. The descriptive polynomial curves do not identify the causes of these fluctuations and were not used for breakpoint detection or forecasting. China and the United States were the leading national contributors, but publication volume should not be equated with scientific quality or clinical influence. China showed a large single-country publication component, whereas the United States and several European countries had comparatively larger multiple-country components. The overall collaboration maps indicate that international connectivity and publication volume are related but distinct dimensions. Because the present analysis did not calculate field-normalized citation impact, journal-level quality, or country-specific citation attractiveness, it cannot determine whether high output translated into proportionately high influence. The source and co-citation analyses further show that the field is anchored in cardiovascular medicine but draws substantially on molecular biology, immunology, physiology, pharmacology, biomaterials, and translational research. Circulation ranked first by publication output in both databases, while other leading sources represented both clinical and experimental traditions. This mixed journal structure is consistent with a field that connects coronary disease, acute care, prognosis, and secondary prevention with immune-cell biology, molecular injury, and tissue repair. The clinical inflammatory risk and prognosis domain was characterized by acute myocardial infarction, ST-segment elevation myocardial infarction, percutaneous coronary intervention, C-reactive protein, interleukins, blood-cell-based indices, biomarkers, mortality, and other outcome-related terms.20,21 This domain reflects the long-standing effort to identify high-risk patients and quantify residual inflammatory risk. Its prominence does not establish that any individual marker has sufficient specificity, causal relevance, or incremental clinical utility for routine decision-making. The coronary vascular inflammation domain included atherosclerosis, coronary artery disease, thrombosis, risk factors, and related vascular terms. This upstream domain is relevant because plaque progression, destabilization, rupture, and thrombosis provide the inflammatory substrate for many myocardial infarctions.8,9 Retaining studies that directly linked vascular inflammation to myocardial infarction risk allowed the map to capture this etiologic continuity without treating broad cardiovascular inflammation as automatically eligible. The post-infarction inflammatory injury and repair domain contained macrophages, monocytes, neutrophils, cytokines, inflammasome-related terms, oxidative stress, apoptosis, pyroptosis, ischemia-reperfusion injury, fibrosis, angiogenesis, and cardiac remodeling.5,22–24 These themes emphasize that inflammation after myocardial infarction is temporally dynamic: early inflammatory activity contributes to debris clearance and host defense, whereas resolution, reparative signaling, scar formation, and later remodeling follow distinct trajectories. Accordingly, serial inflammatory assessment is conceptually more informative than a single measurement when studying treatment windows or patient phenotypes. Taken together, the three-domain framework can be viewed as an inflammation continuum extending from the coronary vascular substrate to clinically measurable inflammatory risk and the downstream injury-repair response. However, this continuum is an interpretive model derived from keyword proximity, thematic evolution, and citation structure. The present analyses did not directly quantify biological transitions, patient-level mediation, or causal connectivity among the domains. The milestone anti-inflammatory trials provide important context for the temporal findings. CANTOS demonstrated that targeting interleukin-1beta signaling could reduce recurrent cardiovascular events in selected patients with prior myocardial infarction, while COLCOT and LoDoCo2 renewed interest in low-dose colchicine for secondary prevention.10–12 A recent review has summarized the broader trial landscape and its translational challenges.25 The current Trend Topics and burst analyses were designed to identify changes in term prominence, not to perform an interrupted time-series analysis or attribute a breakpoint to an individual trial. We therefore interpret the post-2017 increase in anti-inflammatory, biomarker, secondary-prevention, and mechanistic themes as temporally compatible with these milestones, but not as proof of a trial-specific effect on publication behavior. Clinical translation remains unsettled because post-infarction inflammation contains both injury-promoting and repair-supporting phases. Treatment effects are likely to depend on the pathway targeted, timing, dose, background therapy, and patient phenotype.22,24,26 Bibliometric prominence can identify heavily studied markers and pathways, but it does not establish biological importance, causal relevance, analytical validity, clinical utility, or therapeutic efficacy. This distinction is particularly important for recently prominent topics such as NLRP3, systemic immune-inflammatory indices, pyroptosis, ferroptosis, and machine learning. The journal co-citation and dual-map analyses suggest specific forms of interdisciplinary exchange. Molecular and immunological concepts, including macrophage polarization, neutrophil activation, cytokine signaling, inflammasomes, and regulated cell death, increasingly inform cardiovascular studies of infarct size, remodeling, and heart failure. Conversely, clinical frameworks such as reperfusion, percutaneous coronary intervention, C-reactive protein, risk stratification, and major adverse cardiovascular events provide outcome structures through which mechanistic findings are evaluated. These are representative knowledge inflows and outflows inferred at the disciplinary level, not direct evidence that a single concept moved unidirectionally between specific journals. Previous bibliometric studies focused on anti-inflammatory research in coronary heart disease, macrophage-related research after myocardial infarction, or NLRP3 inflammasome research in cardiovascular disease.15–17 The present study extends these narrower perspectives by applying conceptually harmonized searches, relevance screening, separate WoSCC and PubMed analyses, and an explicit temporal comparison across three periods. PubMed was retained because its controlled MeSH indexing provided a complementary biomedical perspective rather than because it increased a pooled sample size or served as formal cross-database validation. The mapped patterns suggest several priorities for future research. Biomarker studies could be integrated more closely with serial immune-cell profiling, cytokine and chemokine measurements, imaging findings, infarct characteristics, and remodeling outcomes. Greater temporal resolution is needed to distinguish inflammatory, resolution, reparative, and remodeling phases. Studies that connect cell-specific or pathway-specific mechanisms with clinically defined phenotypes may help explain why patients with apparently similar systemic inflammatory profiles experience different outcomes. These priorities are hypotheses generated from the literature map and do not support any particular intervention. This study has several limitations. First, WoSCC and PubMed differ in coverage, indexing rules, author and affiliation disambiguation, keyword generation, and citation metadata; the datasets were therefore analyzed separately, and apparent similarities or differences may reflect both database coverage and indexing design. Second, only English-language Articles and Reviews were included. Third, although all records underwent title and abstract eligibility screening and proposed exclusions were independently verified by two authors, relevance judgments remain partly interpretive and some eligible studies may have been missed. Fourth, automatic keyword clustering can generate broad or awkward labels, and the labels should be interpreted with their underlying terms and cluster-quality statistics. Fifth, citation indicators favor older publications and do not measure methodological quality, reproducibility, biological importance, or clinical impact. Sixth, PubMed MeSH analyses may be affected by indexing delays, especially for recent records, and PubMed citation metrics were unavailable. Seventh, the descriptive temporal analyses were not designed to test causal breakpoints associated with specific trials, funding changes, or publication cycles. Finally, this bibliometric study does not evaluate experimental quality, causal relationships, clinical validity, or therapeutic efficacy. Conclusions Myocardial infarction-related inflammation research expanded substantially from 1995 to 2025. Separate analyses of 5,446 WoSCC records and 4,494 PubMed records showed complementary clinical and mechanistic patterns. WoSCC mapping supported an interpretive framework comprising clinical inflammatory risk and prognosis, coronary vascular inflammation, and post-infarction inflammatory injury and repair, while temporal analyses showed a shift toward immune-cell regulation, ischemia-reperfusion injury, inflammasome signaling, systemic immune-inflammatory indices, regulated cell death, and remodeling. These findings describe research prominence and thematic relationships; they do not establish biological causality, clinical validity, or therapeutic efficacy.